Sputnik V
-
RDIF, Hetero to produce 100 million doses of Sputnik V vaccine in India
The parties intend to start the production of Sputnik V in the beginning of 2021 The Russian Direct Investment Fund…
Read More » -
Sputnik V vaccine to cost less than $10 for international markets
RDIF continues expanding existing agreements with international manufacturing partners to produce the vaccine for more than 500 million people in…
Read More » -
Delay in approval may lead to West Bengal lose chance to conduct Phase II trial of Sputnik V
According to a senior official of the health department, several official holidays on account of festivals could have delayed the…
Read More » -
Russian Sputnik V to arrive in Kanpur Medical College for trials
The decision to conduct the human clinical trials of the vaccine was taken after Dr Reddy’s Laboratories got approval from…
Read More » -
Kolkata hospital likely to begin trial of Russia’s COVID-19 vaccine
The health department has awaiting DCGI approval and necessary surveys have been carried out by a site management organisation Phase-II…
Read More » -
RDIF submits application of Sputnik V vaccine to WHO
The Russian Federation has become one of the first countries to apply to WHO for pre-qualification of its vaccine against…
Read More » -
Dr Reddy’s reapplies to DCGI for COVID-19 vaccine trials
Hyderabad-based Dr Reddy’s Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases…
Read More » -
Dr Reddy’s seeks DCGI nod for COVID-19 vaccine
The Hyderabad-based Dr Reddy’s Laboratories has applied to the Drugs Controller General of India (DCGI) for permission to conduct phase-3…
Read More »